Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis. - Wikidata - awgldk - TriplyDB

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.

http://www.wikidata.org/entity/Q38682945

about

Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status.Neurofilament light chain predicts disease activity in relapsing-remitting MS.The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis.Fluid biomarker and electrophysiological outcome measures for progressive MS trials.Fluid biomarkers for microglial activation and axonal injury in multiple sclerosis.Fluid biomarkers for disease activity in multiple sclerosis.Plasma neurofilament light chain concentration in the inherited peripheral neuropathies.Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression.Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome.White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation.Absence of NEFL in patient-specific neurons in early-onset Charcot-Marie-Tooth neuropathy.Serum neurofilament light chain is increased in hereditary spastic paraplegias.Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's disease

P2860

Q47106785-91E01A35-CB86-4A81-ABC9-3362B4D81501 Q47138197-DFBB6796-02DF-4B41-8464-4AD402375032 Q47579410-84B388E1-28A5-4E6C-B76D-E50C5E1642DD Q47638443-EFD1011D-E0C9-4237-AB37-9BFE13858B2E Q47722340-7DD29F8A-7667-40A1-B6B6-FB3BB55843E0 Q49562907-B13A4832-6D8B-4B44-A583-CB403AD1F57B Q50102118-9955A55A-6B42-49DB-97CE-AC4C87988DF0 Q52682490-F6922D9A-E4B1-44A7-B283-3A740F90DCAB Q53074794-D6F6AB73-7F15-40D6-BCD0-492190AE1967 Q53396427-BCF99809-57D7-4AB1-AC65-FF6E1674B841 Q55001192-49DE6148-4CA4-40EE-B093-720813A54849 Q55669686-9D06A887-5CFE-42F8-85BB-0D062EFA75DB Q57161829-0AF62C5D-D44C-42CC-9984-8AD0ABEB9BF6 Q58613374-132BE910-3427-43B9-96EB-CFD00546EF72

P2860

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.

http://www.wikidata.org/entity/Q38682945

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.

@en

type

label

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.

@en

prefLabel

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.

@en

P1433

Q38682945-5C58431A-6F5D-45DF-A1FD-F56EFFD2DBF5

P1476

Q38682945-CE4859A2-5DF3-49CE-A02A-2823C33CD97A

P2093

Q38682945-3D045BFF-20A3-49BB-A8B1-A4ABB9DAD112

Q38682945-540D6BD9-82BB-4019-A543-3EE832DBC5FA

Q38682945-6AB74B20-6288-46BA-AB15-AC8FD44CC2F7

Q38682945-800E250D-9981-4C59-9CB3-E295B42BBEE7

Q38682945-9D842EB7-331E-4DBD-990F-9E4E8C0DB70E

Q38682945-A7710B0F-65D3-4B10-AF62-D86DE311E308

Q38682945-AF940524-4F60-4A2E-8FC0-AF61642B68B8

Q38682945-BEA97B29-8120-4710-970C-FB205E468764

Q38682945-CC41F145-F827-4ED1-8E14-AA48ECF8AEB1

Q38682945-E17D4B23-91AD-4AB0-A704-79E845A50480

P2860

Q38682945-06838585-CB86-428C-BD91-8A157AF17B2A

Q38682945-06FF492C-D85C-4B0D-830C-815E4867047F

Q38682945-0A00AF10-7520-4B41-8BE7-0B12A8DE950C

Q38682945-0A8D3FFA-CFB7-486B-927E-78F83B1ED1DC

Q38682945-0F127533-D26A-4E8D-80F2-39613FA32F4E

Q38682945-10F52982-FC8B-4770-A0CE-B9E080321935

Q38682945-248B5A70-C661-4F4D-9CB0-8484C00E014A

Q38682945-28DEF3FE-9EE1-4D21-A018-287D66311E3D

Q38682945-3C350082-EBDC-4B5E-94A6-564FB8DA65A4

Q38682945-3D68EBB2-9741-49E5-89DB-85F67F90C4C0

P304

Q38682945-2A1FB2C2-A607-458B-9D1F-94F7ACEF2B62

P31

Q38682945-76D8E9E4-6D4B-48DE-B83D-167461853B04

P356

Q38682945-947625B4-B2CF-416C-B8CB-85DA30E121A2

P433

Q38682945-63BB8DCE-EBF4-4964-823A-8D799816CAEF

P478

Q38682945-DC304D90-84BF-41C9-B5EC-41270062CEB3

P50

Q38682945-36FDB8F4-502F-4D2D-90C9-99D30BF4F88E

Q38682945-54A8B9A2-570B-4BE5-BB2A-AEDF63DCD8A3

Q38682945-F819CF36-D54E-4F98-847A-B5CC2B773A98

P577

Q38682945-CE88555E-33F5-4634-8239-4DDE9807D471

P698

Q38682945-296F5481-5B32-4334-BBBA-5F4643866D1C

P921

Q38682945-5B69BD60-8E47-4968-88C0-4BD3BC95DDA1

Q38682945-CC5B76C7-7417-4D90-8C43-5EC4B10303DC

P932

Q38682945-DA7F83A8-C8E1-4949-8C18-D5EBED9EEA4F

P356

P1433

Annals of Neurology

P1476

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.

@en

P2093

Antonella Giardiello

http://www.w3.org/2001/XMLSchema#string

Chiara Zecca

http://www.w3.org/2001/XMLSchema#string

Christian Barro

http://www.w3.org/2001/XMLSchema#string

Claudio Gobbi

http://www.w3.org/2001/XMLSchema#string

David Leppert

http://www.w3.org/2001/XMLSchema#string

Giulio Disanto

http://www.w3.org/2001/XMLSchema#string

Jens Kuhle

http://www.w3.org/2001/XMLSchema#string

Pascal Benkert

http://www.w3.org/2001/XMLSchema#string

Sabine Schädelin

http://www.w3.org/2001/XMLSchema#string

Swiss Multiple Sclerosis Cohort Study Group

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Body fluid biomarkers in multiple sclerosis

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options

Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis

Smooth centile curves for skew and kurtotic data modelled using the Box-Cox power exponential distribution.

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.

Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis

P304

857-870

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.24954

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Zetterberg

P577

2017-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28512753

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

5519945

http://www.w3.org/2001/XMLSchema#string